GSA Capital Partners’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-48,842
| Closed | -$320K | – | 1841 |
|
|
2023
Q4 | $320K | Buy |
+48,842
| New | +$320K | 0.03% | 1083 |
|
|
2023
Q1 | – | Sell |
-54,976
| Closed | -$787K | – | 1771 |
|
|
2022
Q4 | $787K | Buy |
+54,976
| New | +$787K | 0.1% | 335 |
|
|
2022
Q2 | – | Sell |
-10,114
| Closed | -$357K | – | 1660 |
|
|
2022
Q1 | $357K | Buy |
+10,114
| New | +$357K | 0.05% | 768 |
|
|
2021
Q3 | – | Sell |
-8,095
| Closed | -$338K | – | 1653 |
|
|
2021
Q2 | $338K | Buy |
+8,095
| New | +$338K | 0.04% | 867 |
|